Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults
- PMID: 23162014
- PMCID: PMC3826541
- DOI: 10.1161/ATVBAHA.112.300421
Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults
Abstract
Objective: CD14 is a glycosylphosphotidylinositol-anchored membrane glycoprotein expressed on neutrophils and monocytes/macrophages that also circulates as a soluble form (sCD14). Despite the well-recognized role of CD14 in inflammation, relatively little is known about the genetic determinants of sCD14 or the relationship of sCD14 to vascular- and aging-related phenotypes.
Methods and results: We measured baseline levels of sCD14 in >5000 European-American and black adults aged 65 years and older from the Cardiovascular Health Study, who were well characterized at baseline for atherosclerotic risk factors and subclinical cardiovascular disease, and who have been followed for clinical cardiovascular disease and mortality outcomes up to 20 years. At baseline, sCD14 generally showed strong positive correlations with traditional cardio-metabolic risk factors and with subclinical measures of vascular disease such as carotid wall thickness and ankle-brachial index (independently of traditional cardiovascular disease risk factors), and was also inversely correlated with body mass index. In genomewide association analyses of sCD14, we (1) confirmed the importance of the CD14 locus on chromosome 5q21 in European-American; (2) identified a novel African ancestry-specific allele of CD14 associated with lower sCD14 in blacks; and (3) identified a putative novel association in European-American of a nonsynonymous variant of PIGC, which encodes an enzyme required for the first step in glycosylphosphotidylinositol anchor biosynthesis. Finally, we show that, like other acute phase inflammatory biomarkers, sCD14 predicts incident cardiovascular disease, and strongly and independently predicts all-cause mortality in older adults.
Conclusions: CD14 independently predicts risk mortality in older adults.
Figures



Similar articles
-
Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):e369-e378. doi: 10.1161/ATVBAHA.121.316035. Epub 2021 Apr 29. Arterioscler Thromb Vasc Biol. 2021. PMID: 33910371 Free PMC article.
-
Soluble CD14, Ischemic Stroke, and Coronary Heart Disease Risk in a Prospective Study: The REGARDS Cohort.J Am Heart Assoc. 2020 Mar 17;9(6):e014241. doi: 10.1161/JAHA.119.014241. Epub 2020 Mar 11. J Am Heart Assoc. 2020. PMID: 32157955 Free PMC article.
-
Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.J Thromb Haemost. 2018 Jan;16(1):19-30. doi: 10.1111/jth.13899. Epub 2017 Dec 8. J Thromb Haemost. 2018. PMID: 29112333 Free PMC article.
-
APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):398-403. doi: 10.1161/ATVBAHA.115.305970. Epub 2015 Dec 3. Arterioscler Thromb Vasc Biol. 2016. PMID: 26634651 Free PMC article.
-
Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.Thromb Haemost. 2008 Feb;99(2):388-95. doi: 10.1160/TH07-08-0523. Thromb Haemost. 2008. PMID: 18278190
Cited by
-
Association between yogurt consumption and plasma soluble CD14 in two prospective cohorts of US adults.Eur J Nutr. 2021 Mar;60(2):929-938. doi: 10.1007/s00394-020-02303-3. Epub 2020 Jun 16. Eur J Nutr. 2021. PMID: 32548645 Free PMC article.
-
rs2569190A>G in CD14 is Independently Associated with Hypercholesterolemia: A Brief Report.J Cardiovasc Dev Dis. 2019 Oct 30;6(4):37. doi: 10.3390/jcdd6040037. J Cardiovasc Dev Dis. 2019. PMID: 31671579 Free PMC article.
-
Soluble CD14 and Incident Diabetes Risk: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.J Endocr Soc. 2024 May 23;8(7):bvae097. doi: 10.1210/jendso/bvae097. eCollection 2024 May 23. J Endocr Soc. 2024. PMID: 38817635 Free PMC article.
-
Association of CD14 with incident dementia and markers of brain aging and injury.Neurology. 2020 Jan 21;94(3):e254-e266. doi: 10.1212/WNL.0000000000008682. Epub 2019 Dec 9. Neurology. 2020. PMID: 31818907 Free PMC article.
-
Monocyte activation and gut barrier dysfunction in South African youth on antiretroviral therapy and their associations with endothelial dysfunction.AIDS. 2020 Sep 1;34(11):1615-1623. doi: 10.1097/QAD.0000000000002615. AIDS. 2020. PMID: 32769763 Free PMC article.
References
-
- Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol. 1988;141:547–52. - PubMed
-
- Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249:1431–3. - PubMed
-
- Tobias PS, Ulevitch RJ. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology. 1993;187:227–32. - PubMed
-
- Bazil V, Baudys M, Hilgert I, Stefanová I, Low MG, Zbrozek J, Horejsí V. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol. 1989;26:657–62. - PubMed
-
- Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol. 1991;147:1567–1574. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL080295R01/HL/NHLBI NIH HHS/United States
- N01-HC-85085/HC/NHLBI NIH HHS/United States
- N01-HC-85081/HC/NHLBI NIH HHS/United States
- R56 AG020098/AG/NIA NIH HHS/United States
- N01-HC-85086/HC/NHLBI NIH HHS/United States
- AG-027058/AG/NIA NIH HHS/United States
- N01-HC-85082/HC/NHLBI NIH HHS/United States
- N01 HC-55222/HC/NHLBI NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- R01 HL080295/HL/NHLBI NIH HHS/United States
- T32 GM007092/GM/NIGMS NIH HHS/United States
- R01 AG020098/AG/NIA NIH HHS/United States
- N01-HC-85079/HC/NHLBI NIH HHS/United States
- N01-HC-85084/HC/NHLBI NIH HHS/United States
- R01 AG015928/AG/NIA NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01 HC015103/HC/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- AG-20098/AG/NIA NIH HHS/United States
- 268201200036C/PHS HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- N01-HC-85083/HC/NHLBI NIH HHS/United States
- N01-HC-75150/HC/NHLBI NIH HHS/United States
- N01-HC-85080/HC/NHLBI NIH HHS/United States
- R01 HL071862/HL/NHLBI NIH HHS/United States
- HL71862/HL/NHLBI NIH HHS/United States
- N01-HC-85239/HC/NHLBI NIH HHS/United States
- AG-023629/AG/NIA NIH HHS/United States
- N01 HC075150/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- R01 AG027058/AG/NIA NIH HHS/United States
- N01 HC045133/HC/NHLBI NIH HHS/United States
- N01 HC035129/HC/NHLBI NIH HHS/United States
- R56 AG023629/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials